Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus
- PMID: 17926232
- DOI: 10.1055/s-2007-985148
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus
Abstract
Fibroplast growth factor (FGF-21) is a recently discovered metabolic regulator. Its pathophysiologic role in humans remains unknown. In this study, we have investigated whether or not plasma FGF-21 level was different in patients with type 2 diabetes mellitus (T2DM) and non-diabetic controls. We also assessed associations between plasma FGF-21 body composition and several metabolic parameters. Fasting FGF-21 levels were significantly increased in patients with T2DM compared with controls (1.82+/-0.65 VS. 1.53+/-0.60 microg/L, P<0.05). In T2DM patients, fasting plasma FGF-21 correlate negatively with fasting blood glucose ( R= -0.31, P<0.05). Multiple regression analysis showed that FBG, plasma insulin and HOMA (IS) were independent influencing plasma FGF-21 levels. The present work suggests a potential role for FGF-21 in the pathogenesis of insulin resistance and T2DM.
Similar articles
-
Serum FGF-21 levels in type 2 diabetic patients.Endocr Res. 2011;36(4):142-8. doi: 10.3109/07435800.2011.558550. Endocr Res. 2011. PMID: 21973233
-
Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus.Eur J Endocrinol. 2009 Sep;161(3):391-5. doi: 10.1530/EJE-09-0335. Epub 2009 Jun 15. Eur J Endocrinol. 2009. PMID: 19528204 Clinical Trial.
-
Plasma FGF-21 levels in type 2 diabetic patients with ketosis.Diabetes Res Clin Pract. 2008 Nov;82(2):209-13. doi: 10.1016/j.diabres.2008.07.012. Epub 2008 Aug 22. Diabetes Res Clin Pract. 2008. PMID: 18722685
-
Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.Diabetes Technol Ther. 2016 Mar;18(3):120-6. doi: 10.1089/dia.2015.0261. Epub 2016 Mar 7. Diabetes Technol Ther. 2016. PMID: 26950284
-
Roles of fibroblast growth factors in the treatment of diabetes.World J Diabetes. 2024 Mar 15;15(3):392-402. doi: 10.4239/wjd.v15.i3.392. World J Diabetes. 2024. PMID: 38591079 Free PMC article. Review.
Cited by
-
Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes.J Endocr Soc. 2024 Jan 24;8(4):bvae008. doi: 10.1210/jendso/bvae008. eCollection 2024 Feb 19. J Endocr Soc. 2024. PMID: 38379856 Free PMC article.
-
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.Int J Mol Sci. 2023 Dec 9;24(24):17298. doi: 10.3390/ijms242417298. Int J Mol Sci. 2023. PMID: 38139126 Free PMC article. Review.
-
The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China.BMC Endocr Disord. 2023 Sep 1;23(1):188. doi: 10.1186/s12902-023-01426-y. BMC Endocr Disord. 2023. PMID: 37658393 Free PMC article.
-
The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus.Diagnostics (Basel). 2023 Jan 22;13(3):399. doi: 10.3390/diagnostics13030399. Diagnostics (Basel). 2023. PMID: 36766504 Free PMC article.
-
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet.Front Nutr. 2023 Jan 25;10:1058364. doi: 10.3389/fnut.2023.1058364. eCollection 2023. Front Nutr. 2023. PMID: 36761216 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical